Windtree Therapeutics, a NASDAQ-listed biotech firm, is making headlines after signing a landmark $60 million agreement with Build and Build Corp. to launch a crypto-focused treasury strategy centered on BNB.
The deal includes an option for an additional $140 million, potentially bringing total funding to $200 million.
Once finalized and approved by shareholders, Windtree is set to become the first company on NASDAQ to hold direct exposure to BNB, the native token of the Binance ecosystem.
The investment will be delivered through a mix of cash, BNB tokens, and shares in the Osprey BNB Chain Trust. Proceeds will fund Windtree’s new treasury strategy, which aims to integrate custody, security, and yield-generation mechanisms around BNB holdings.
“This initiative brings U.S. investors a new way to access BNB,” said Patrick Horsman of Build and Build Corp., who called it a major step in bridging traditional finance with the crypto economy.
Alexander Zdravkov
Reporter at Coindoo
Alexander Zdravkov is a person who always looks for the logic behind things. He is fluent in German and has more than 3 years of experience in the crypto space, where he skillfully identifies new trends in the world of digital currencies. Whether providing in-depth analysis or daily reports on all topics, his deep understanding and enthusiasm for what he does make him a valuable member of the team.
Source: https://coindoo.com/windtree-becomes-first-nasdaq-firm-to-back-bnb-with-200m-crypto-strategy/